Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, ...
BACKGROUND: A 3-dimensional hyperboloid model has been proposed to characterize ventricular tachycardia (VT) circuitry. We ...
Introduction Although there are some drugs to control Parkinson’s disease (PD), they have several side effects and cannot ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback